• Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at Canaccord Genuity Group

    Источник: Buzz FX / 18 мар 2025 11:56:16   America/New_York


    Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at Canaccord Genuity Group Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" r
    Read more...
Опубликовать